Original Research

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study

LaForce C, Feldman G, Spangenthal S, Eckert JH, Henley M, Patalano F, D’Andrea P

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1233-1243

Published Date: 8 June 2016